New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

LR Health & Beauty SE · ISIN: NO0013149658 · EQS - Company News (7 News)
Country: Germany · Primary market: Norway · EQS NID: 1866775
26 March 2024 11:00AM

Shareholder Quadriga Capital wins Evoco as major investor / Investors provide additional capital to fund successful growth strategy


EQS-News: LR Health & Beauty SE / Key word(s): Financing
LR Health & Beauty SE: Shareholder Quadriga Capital wins Evoco as major investor / Investors provide additional capital to fund successful growth strategy

26.03.2024 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


LR Health & Beauty SE: Shareholder Quadriga Capital wins Evoco as major investor / Investors provide additional capital to fund successful growth strategy

  • Quadriga Capital wins Evoco as major investor for LR Health & Beauty
  • Investors support successful growth strategy with additional capital
  • Settlement of New Bond 2024/2028 completed 

Ahlen, 26 March 2024 – LR Health & Beauty SE, Europe’s leading digital social selling platform in the area of high-quality health and beauty products, is attracting considerable interest from bondholders and investors with its social selling business model and clear corporate strategy. Quadriga Capital has now won private equity firm Evoco as a major investor in LR Health & Beauty. This is followed by further capital injection into the Company, providing LR Health & Beauty with more financial backing to further drive its strategic initiatives.

In addition, LR Health & Beauty SE has successfully placed its EUR 130 million New Bond (ISIN NO0013149658) with institutional investors, mainly from Germany and the rest of Europe. Settlement of the New Bond has now been completed. This provides the issuer of the legacy bond 2021/2024, LR Global Holding GmbH, with proceeds of approx. EUR 125 million for the premature refinancing of this bond.

Dr Andreas Laabs, CEO of LR Health & Beauty SE, said: “We are delighted that our business model and our strategy have been so well received by investors. This gives us the flexibility we need to execute our business strategy. 2024 is off to a very good start and we will now focus not only on further optimising our distribution model and launching new product innovations, but also on further digitalising our business processes. With our new digital platform, LR neo, we have created a central information hub for our partners, which we will expand to provide them with all the information they need to pursue their business activities.”


LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality health and beauty products in 32 countries. As an attractive social selling company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.


Your Contacts:

PR Contact:

LR Global Holding 
Almut Kellermeyer  
Head of Corporate Communication 
Kruppstraße 55 
59227 Ahlen 
Phone: +49(0)2382 7813-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

 

IR Contact:

cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de



26.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: LR Health & Beauty SE
Kruppstr. 55
59227 Ahlen
Germany
Phone: +49 238270600
E-mail: info@lrworld.com
Internet: www.lrworld.com
ISIN: NO0013149658
WKN: A3H3FM
Listed: Regulated Unofficial Market in Frankfurt; Stockholm
EQS News ID: 1866775

 
End of News EQS News Service

1866775  26.03.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1866775&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.